ESR1 Antibody | CSB-PA11399A0Rb

(No reviews yet) Write a Review
SKU:
CSB-PA11399A0Rb
Availability:
3 to 7 Working Days
  • ESR1 Antibody
  • Western blot<br />
 All lanes: ESR1 antibody at 7µg/ml<br />
 Lane 1: Hela whole cell lysate<br />
 Lane 2: MCF-7 whole cell lysate<br />
 Lane 3: Rat brain tissue<br />
 Lane 4: Colo320 whole cell lysate<br />
 Secondary<br />
 Goat polyclonal to rabbit IgG at 1/10000 dilution<br />
 Predicted band size: 67, 54, 48, 36 kDa<br />
 Observed band size: 67 kDa<br />
  • Immunohistochemistry of paraffin-embedded human breast cancer using CSB-PA11399A0Rb at dilution of 1:100
  • Chromatin Immunoprecipitation MCF-7 (1.1*10<sup>6</sup>) were cross-linked with formaldehyde, sonicated, and immunoprecipitated with 4µg anti-ESR1 or a control normal rabbit IgG. The resulting ChIP DNA was quantified using real-time PCR with primers (CSB-PP11399HU) against the ESR1 promoter.
$378.96 - $586.44

Description

ESR1 Antibody | CSB-PA11399A0Rb | Cusabio

ESR1 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: ESR1

Aliases: Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), ESR1, ESR NR3A1

Background: Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Isoform 3 can bind to ERE and inhibit isoform 1.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: P03372

Host Species: Rabbit

Species Reactivity: Human, Rat

Immunogen: Recombinant Human Estrogen receptor protein (10-591AA)

Immunogen Species: Human

Applications: ELISA, WB, IHC, ChIP

Tested Applications: ELISA, WB, IHC, ChIP; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

Purification Method: >95%, Protein G purified

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: WB:1:1000-1:5000

Dilution Ratio3: IHC:1:20-1:200

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Signal Transduction

Research Areas: Epigenetics & Nuclear Signaling;Neuroscience;Cancer;Signal transduction

View AllClose

0 Reviews

View AllClose